Disruption of KDM6A, a histone lysine demethylase, is one of the most common somatic alternations in bladder cancer. Insights into how KDM6A mutations impact the epigenetic landscape to promote carcinogenesis could help reveal potential new treatment approaches. Here, we demonstrated that KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and induces a neoplastic state characterized by increased cell proliferation. In bladder cancer cells with intact KDM6A, FOXA1 interacted with KDM6A to activate genes instructing urothelial differentiation. KDM6A-deficient cells displayed simultaneous loss of FOXA1 target binding and genome-wide redistribution of the bZIP transcription factor ATF3, which in turn repressed FOXA1-target genes and activated cell cycle progression genes. Importantly, ATF3 depletion reversed the cell proliferation phenotype induced by KDM6A deficiency. These data establish that KDM6A loss engenders an epigenetic state that drives tumor growth in an ATF3-dependent manner, creating a potentially targetable molecular vulnerability.
Cancer research. 2023 Jan 13 [Epub ahead of print]
Hong Qiu, Vladimir Makarov, Jennifer K Bolzenius, Angela Halstead, Yvonne Parker, Allen Wang, Gopakumar V Iyer, Hannah Wise, Daniel Kim, Varna Thayaparan, Daniel J Lindner, Georges-Pascal Haber, Angela H Ting, Bing Ren, Timothy A Chan, Vivek Arora, David B Solit, Byron H Lee
Cleveland Clinic, Cleveland, OH, United States., Memorial Sloan Kettering Cancer Center, Cleveland, OH, United States., Washington University in St. Louis School of Medicine, St. Louis, MO, United States., Cleveland Clinic, Cleveland, Ohio, United States., University of California - San Diego School of Medicine, San Diego, CA, United States., Memorial Sloan Kettering Cancer Center, New York, NY, United States., Memorial Sloan Kettering Cancer Center, New York, New York, United States., Cleveland Clinic Foundation, Cleveland, OH, United States., University of California, San Diego, La Jolla, CA, United States., Washington University in St. Louis, St. Louis, MO, United States.